Literature DB >> 18297660

Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues.

Eric Biron1, Jayanta Chatterjee, Oded Ovadia, Daniel Langenegger, Joseph Brueggen, Daniel Hoyer, Herbert A Schmid, Raz Jelinek, Chaim Gilon, Amnon Hoffman, Horst Kessler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18297660     DOI: 10.1002/anie.200705797

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  64 in total

1.  Generating orally active galanin analogues with analgesic activities.

Authors:  Charles R Robertson; Timothy H Pruess; Erin Grussendorf; H Steve White; Grzegorz Bulaj
Journal:  ChemMedChem       Date:  2012-02-28       Impact factor: 3.466

2.  Pharmacokinetic and pharmacodynamic evidence for developing an oral formulation of octreotide against gastric mucosal injury.

Authors:  Xi-Nuo Li; Tai Rao; Yang-Fan Xu; Kang-Rui Hu; Zhang-Pei Zhu; Hao-Feng Li; Dian Kang; Yu-Hao Shao; Bo-Yu Shen; Xiao-Xi Yin; Lin Xie; Guang-Ji Wang; Yan Liang
Journal:  Acta Pharmacol Sin       Date:  2017-11-30       Impact factor: 6.150

3.  EPSA: A Novel Supercritical Fluid Chromatography Technique Enabling the Design of Permeable Cyclic Peptides.

Authors:  Gilles H Goetz; Laurence Philippe; Michael J Shapiro
Journal:  ACS Med Chem Lett       Date:  2014-08-04       Impact factor: 4.345

4.  Permeability of Cyclic Peptide Macrocycles and Cyclotides and Their Potential as Therapeutics.

Authors:  Spiros Liras; Kim F Mcclure
Journal:  ACS Med Chem Lett       Date:  2019-06-14       Impact factor: 4.345

5.  Macrocyclic peptides: Tying up loose ends.

Authors:  Fumito Saito; Jeffrey W Bode
Journal:  Nat Chem       Date:  2016-11-22       Impact factor: 24.427

6.  Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance().

Authors:  Arthur C Rand; Siegfried S F Leung; Heather Eng; Charles J Rotter; Raman Sharma; Amit S Kalgutkar; Yizhong Zhang; Manthena V Varma; Kathleen A Farley; Bhagyashree Khunte; Chris Limberakis; David A Price; Spiros Liras; Alan M Mathiowetz; Matthew P Jacobson; R Scott Lokey
Journal:  Medchemcomm       Date:  2012-10       Impact factor: 3.597

Review 7.  Impact of physiochemical properties on pharmacokinetics of protein therapeutics.

Authors:  Rajan Swami; Aliasgar Shahiwala
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-04-14       Impact factor: 2.441

8.  Almiramides A-C: discovery and development of a new class of leishmaniasis lead compounds.

Authors:  Laura M Sanchez; Dioxelis Lopez; Brian A Vesely; Gina Della Togna; William H Gerwick; Dennis E Kyle; Roger G Linington
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

9.  Tuning of protease resistance in oligopeptides through N-alkylation.

Authors:  Revital Kaminker; Athina Anastasaki; Will R Gutekunst; Yingdong Luo; Sang-Ho Lee; Craig J Hawker
Journal:  Chem Commun (Camb)       Date:  2018-08-23       Impact factor: 6.222

Review 10.  Direct Activation of Bax Protein for Cancer Therapy.

Authors:  Zhiqing Liu; Ye Ding; Na Ye; Christopher Wild; Haiying Chen; Jia Zhou
Journal:  Med Res Rev       Date:  2015-09-23       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.